Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study

医学 放射外科 期限(时间) 医学物理学 多中心研究 梅德林 放射科 外科 放射治疗 随机对照试验 天文 政治学 物理 法学
作者
Andréanne Hamel,Jean-Nicolas Tourigny,Ajay Niranjan,L. Dade Lunsford,Zhishuo Wei,Priyanka Srinivasan,Roman Liščák,Jaromír May,Nuria Martínez Moreno,Roberto Martínez Álvarez,Cheng‐Chia Lee,Huai‐Che Yang,Manjul Tripathi,Narendra Kumar,Elad Mashiach,Douglas Kondziolka,Robert G. Briggs,Cheng Yu,Gabriel Zada,Andrea Franzini,Guido Pecchioli,Gregory Bowden,Sam Dayawansa,Jason P. Sheehan,David Mathieu
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
标识
DOI:10.1227/neu.0000000000003261
摘要

BACKGROUND AND OBJECTIVES: Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study was designed to provide multi-institutional data to evaluate the results of stereotactic radiosurgery (SRS) for pineocytomas. METHODS: Centers participating in the International Radiosurgery Research Foundation were asked to review their database and provide data for patients who had SRS for histology confirmed grade 1 pineocytomas, for whom clinical and imaging follow-up of at least 6 months was available. RESULTS: In total, 38 patients underwent SRS as part of the management of a pineocytoma. The median age at SRS was 39 years (range 8-76). SRS was performed as primary approach in 68%, adjuvant after partial resection 19%, and at recurrence in 13% of patients. The median margin dose was 15 Gy (range 11-25 Gy). The median treatment volume was 3.35 cc (range 0.1-17.9 cc). Local tumor control was achieved in 92% of patients, with a mean actuarial progression-free survival of 21.6 years (median not reached). At last follow-up, 82% were still controlled, 8% had local recurrence, and 10% had cerebrospinal fluid dissemination. Tumor control was significantly better when SRS was used as primary care compared with the adjuvant or recurrent setting ( P = .016). Five patients (13%) died during follow-up, all from tumor progression. The actuarial mean survival duration was 24.3 years, with a 5-year survival rate of 91%, and an estimated rate of 76% at 29 years. Larger tumor volume at SRS was found to be correlated to increased risk of death ( P = .045). Transient symptomatic adverse radiation effects were observed in 4 patients (11%). CONCLUSION: SRS appears safe and effective for the management of pineocytomas. Long-term tumor control is achieved in most cases. SRS can be offered to selected patients as an alternative to surgical resection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
75986686完成签到,获得积分10
刚刚
hearz发布了新的文献求助10
刚刚
负责金毛完成签到,获得积分10
刚刚
fan051500完成签到,获得积分10
1秒前
清脆乐曲完成签到,获得积分10
1秒前
arzw完成签到,获得积分10
1秒前
勤奋的天亦完成签到,获得积分10
2秒前
2秒前
哒哒哒完成签到,获得积分10
2秒前
天水张家辉完成签到,获得积分10
2秒前
2秒前
乐一李完成签到,获得积分10
3秒前
ding应助无敌是多么寂寞采纳,获得10
3秒前
zyyyyyyyy完成签到 ,获得积分10
3秒前
会飞的蜗牛完成签到,获得积分10
3秒前
沉默的凝荷完成签到,获得积分10
3秒前
布小丁完成签到,获得积分20
4秒前
lv完成签到,获得积分10
4秒前
pikachu完成签到,获得积分10
4秒前
KYTHUI完成签到,获得积分10
4秒前
贺兰鸵鸟完成签到,获得积分10
5秒前
Rain1god完成签到,获得积分10
5秒前
kma完成签到,获得积分10
5秒前
南方周末完成签到,获得积分10
5秒前
凌代萱完成签到 ,获得积分10
6秒前
阿哲完成签到,获得积分10
6秒前
myuniv发布了新的文献求助10
6秒前
莫x莫完成签到 ,获得积分10
6秒前
Tingshan完成签到,获得积分10
6秒前
静待花开完成签到 ,获得积分10
6秒前
7秒前
叶子完成签到,获得积分10
7秒前
SciGPT应助会飞的蜗牛采纳,获得10
8秒前
布小丁发布了新的文献求助10
8秒前
Treasure完成签到,获得积分10
9秒前
9秒前
xiamovivi完成签到,获得积分10
11秒前
11秒前
自由的凡白完成签到,获得积分10
11秒前
三叶草完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Architectural Corrosion and Critical Infrastructure 1000
Electrochemistry: Volume 17 600
Physical Chemistry: How Chemistry Works 500
SOLUTIONS Adhesive restoration techniques restorative and integrated surgical procedures 500
Energy-Size Reduction Relationships In Comminution 500
Principles Of Comminution, I-Size Distribution And Surface Calculations 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4946045
求助须知:如何正确求助?哪些是违规求助? 4210330
关于积分的说明 13087390
捐赠科研通 3990895
什么是DOI,文献DOI怎么找? 2184843
邀请新用户注册赠送积分活动 1200218
关于科研通互助平台的介绍 1113922